PRR shRNA reversed the diabetes-induced decrease of pAMPK/tAMPK and SIRT-1 protein expression (Fig 4A and 4B), and the levels were similar to that of PRR shRNA treated non-diabetic animals. This evidence concerns the gene ATP6AP2 and diabetes mellitus.